Freeline scores $80m Series C
UK-based Freeline, a developer of curative gene therapies for chronic systemic diseases, has raised $80 million in Series C funding.
1 July 2020•1 min read
UK-based Freeline, a developer of curative gene therapies for chronic systemic diseases, has raised $80 million in Series C funding.
Singapore VC plants flag in Ohio in search of US investors
26 October 2026 · 6 mins read
New AI threats are fueling VC investment in cybersecurity
22 October 2026 · 4 mins read
Inspired Capital holds quick close on $450m for Fund IV
20 October 2026 · 4 mins read
Inovia hits $200m in first close for sixth early-stage fund
19 October 2026 · 4 mins read
San Joaquin County to slow venture commitments
15 October 2026 · 2 mins read
DOWNLOAD: Fundraising holds steady in Q3
14 October 2026 · 2 mins read
Why Endeavor Catalyst is betting big on Southeast Asia
8 October 2026 · 4 mins read
